These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6740737)

  • 1. Variability of plasma phenobarbitone concentration in Asian children in Singapore.
    Lee HS
    Ther Drug Monit; 1984; 6(2):182-8. PubMed ID: 6740737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore.
    Lee HS; Chan KY
    Ther Drug Monit; 1981; 3(3):247-52. PubMed ID: 7324089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma levels of phenobarbital in epileptic children. Effect of combination with other anticonvulsants].
    Benedetti P; Antonozzi I; Curatolo P; Porro G
    Arch Fr Pediatr; 1979; 36(7):686-90. PubMed ID: 533347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbitone in previously untreated epilepsy.
    Feely M; O'Callagan M; Duggan B; Callaghan N
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):365-8. PubMed ID: 7373337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Br J Clin Pharmacol; 1977 Oct; 4(5):541-7. PubMed ID: 911604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of phenobarbitone in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):18-22. PubMed ID: 3104216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with the EMIT method of determining anticonvulsant levels in serum.
    Leary PM; Berger GM; Weer L; Prinsloo H
    S Afr Med J; 1977 Jan; 51(5):137-9. PubMed ID: 850846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of phenobarbitone population clearance values for physically and mentally handicapped Chinese children with epilepsy.
    Chan E; Chan K; Teoh R
    J Clin Pharm Ther; 1997; 22(5-6):399-403. PubMed ID: 19160725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between age and plasma level/dosage ratio for phenobarbital in infants and children.
    Rossi LN; Nino LM; Principi N
    Acta Paediatr Scand; 1979 May; 68(3):431-4. PubMed ID: 443043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.
    Bekele G; Abebe Y; T'Haimanot R
    Ethiop Med J; 1990 Jan; 28(1):23-30. PubMed ID: 2307155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels.
    Hughes K; Yeo PP; Lun KC; Thai AC; Sothy SP; Wang KW; Cheah JS; Phoon WO; Lim P
    J Epidemiol Community Health; 1990 Mar; 44(1):29-35. PubMed ID: 2348145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore.
    Hughes K; Ong CN
    J Epidemiol Community Health; 1998 Mar; 52(3):181-5. PubMed ID: 9616423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phenobarbitone N-glucosidation by valproate.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Br J Clin Pharmacol; 1994 Nov; 38(5):411-6. PubMed ID: 7893581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue therapy with high-dose oral phenobarbitone loading for refractory status epilepticus.
    Wilmshurst JM; van der Walt JS; Ackermann S; Karlsson MO; Blockman M
    J Paediatr Child Health; 2010 Jan; 46(1-2):17-22. PubMed ID: 19943867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phenobarbitone estimation in epilepsy.
    Shukla R; Agarwal SK; Nag D; Gupta NN; Kar AM
    J Assoc Physicians India; 1982 Aug; 30(8):505-7. PubMed ID: 7169485
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
    Hughes K; Ong CN
    J Epidemiol Community Health; 2000 Jan; 54(1):31-4. PubMed ID: 10692959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.